Cognito Therapeutics has enrolled the first patient in a biomarker substudy within its HOPE pivotal trial evaluating sensory stimulation device in Alzheimer’s disease patients.
Related:...
Arizona-based Nectero Medical has initiated a Phase II/III trial evaluating the safety and efficacy of its endovascular aneurysm stabilisation treatment (Nectero EAST).
Nectero EAST is...
OrganOx and eGenesis have announced the successful completion of an extracorporeal perfusion of a brain-dead research donor using a genetically engineered porcine liver. The...
Onward Medical has started a Netherlands-based clinical feasibility study to assess its ARC-IM neurostimulator’s ability to improve haemodynamic instability in spinal cord injury (SCI)...
Photobiomodulation device firm, LumiThera, has announced the launch of a new clinical registry study designed to collect safety and efficacy data from patients living...
Astent system designed by Reflow Medical to treat de novo or restenotic lesions in the infrapopliteal arteries has been awarded a CE mark.
US-based cardiovascular...
The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval for Endovascular Engineering’s trial investigating its Hēlo Thrombectomy System in...
US-based Nexalin Technology has unveiled a third-generation HALO Clarity 15 milliamp (mA) neurostimulation device.
The company plans to conduct decentralised clinical trials for the HALO...
Neuralace Medical has received US Food and Drug Administration (FDA) clearance of Axon Therapy to treat chronic Painful Diabetic Neuropathy (PDN).
Related: 3Spine completes enrolment...
